|The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs|
FG Lyons, AA Al-Munajjed, SM Kieran, ME Toner, CM Murphy, GP Duffy, ...
Biomaterials 31 (35), 9232-9243, 2010
|Innovative Collagen Nano‐Hydroxyapatite Scaffolds Offer a Highly Efficient Non‐Viral Gene Delivery Platform for Stem Cell‐Mediated Bone Formation|
CM Curtin, GM Cunniffe, FG Lyons, K Bessho, GR Dickson, GP Duffy, ...
Advanced Materials, 2012
|Bone Marrow–Derived Mesenchymal Stem Cells Promote Angiogenic Processes in a Time-and Dose-Dependent Manner In Vitro|
GP Duffy, T Ahsan, T O'Brien, F Barry, RM Nerem
Tissue Engineering Part A 15 (9), 2459-2470, 2009
|Drug and cell delivery for cardiac regeneration|
CL Hastings, ET Roche, E Ruiz-Hernandez, K Schenke-Layland, ...
Advanced drug delivery reviews 84, 85-106, 2015
|Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart|
ET Roche, CL Hastings, SA Lewin, DE Shvartsman, Y Brudno, ...
Biomaterials 35 (25), 6850-6858, 2014
|Combinatorial gene therapy accelerates bone regeneration: non‐viral dual delivery of VEGF and BMP2 in a collagen‐nanohydroxyapatite scaffold|
CM Curtin, EG Tierney, K McSorley, SA Cryan, GP Duffy, FJ O'Brien
Advanced healthcare materials 4 (2), 223-227, 2015
|The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen–glycosaminoglycan scaffold in vivo|
TM McFadden, GP Duffy, AB Allen, HY Stevens, SM Schwarzmaier, ...
Acta biomaterialia 9 (12), 9303-9316, 2013
|Towards in vitro vascularisation of collagen-GAG scaffolds|
GP Duffy, TM McFadden, EM Byrne, SL Gill, E Farrell, FJ O’Brien
European cells & materials 12 (21), 15-30, 2011
|Supramolecular hydrogels with reverse thermal gelation properties from (oligo) tyrosine containing block copolymers|
J Huang, CL Hastings, GP Duffy, HM Kelly, J Raeburn, DJ Adams, ...
|The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds|
EG Tierney, GP Duffy, AJ Hibbitts, SA Cryan, FJ O'Brien
Journal of Controlled Release, 2011
|Mechanical characterisation of a customised decellularized scaffold for vascular tissue engineering|
WS Sheridan, GP Duffy, BP Murphy
Journal of the Mechanical Behavior of Biomedical Materials, 2011
|RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells|
LE Mulcahy, D Taylor, TC Lee, GP Duffy
Bone 48 (2), 182-188, 2011
|A novel collagen-nanohydroxyapatite microRNA-activated scaffold for tissue engineering applications capable of efficient delivery of both miR-mimics and antagomiRs to human …|
IM Castaño, CM Curtin, G Shaw, JM Murphy, GP Duffy, FJ O'Brien
Journal of Controlled Release 200, 42-51, 2015
|Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of …|
CL Hastings, HM Kelly, MJ Murphy, FP Barry, FJ O'Brien, GP Duffy
Journal of Controlled Release, 2012
|Gene-eluting stents: comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivo|
F Sharif, SO Hynes, J McMahon, R Cooney, S Conroy, P Dockery, G Duffy, ...
Human gene therapy 17 (7), 741-750, 2006
|Delivering nucleic‐acid based nanomedicines on biomaterial scaffolds for orthopedic tissue repair: challenges, progress and future perspectives|
RM Raftery, DP Walsh, IM Castaño, A Heise, GP Duffy, SA Cryan, ...
Advanced Materials 28 (27), 5447-5469, 2016
|Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems|
M van Elk, BP Murphy, T Eufrásio-da-Silva, DP O’Reilly, T Vermonden, ...
International journal of pharmaceutics 515 (1-2), 132-164, 2016
|Temporal and spatial changes in cartilage-matrix-specific gene expression in mesenchymal stem cells in response to dynamic compression|
MG Haugh, EG Meyer, SD Thorpe, T Vinardell, GP Duffy, DJ Kelly
Tissue Engineering Part A 17 (23-24), 3085-3093, 2011
|Next generation bone tissue engineering: non-viral miR-133a inhibition using collagen-nanohydroxyapatite scaffolds rapidly enhances osteogenesis|
IM Castaño, CM Curtin, GP Duffy, FJ O’Brien
Scientific Reports 6, 27941, 2016
|Biomaterial‐enhanced cell and drug delivery: lessons learned in the cardiac field and future perspectives|
HS O'Neill, LB Gallagher, J O'Sullivan, W Whyte, C Curley, E Dolan, ...
Advanced materials 28 (27), 5648-5661, 2016